The Mayo Clinic Cancer Center (MCCC) is fully committed to addressing cancer-related determinants and outcomes through its leadership in basic, translational, and population sciences cancer research. The MCCC has re-defined its catchment areas (CAs) at its 3 sites as the counties where Mayo Clinic has a physical presence (clinic/hospital), plus the geographically contiguous counties that these sites serve. The Community Outreach and Engagement (COE) effort is led by Dr. Carmen Radecki Breitkopf, Associate Director for Cancer Disparities and Community Outreach.
COE Specific Aims i nclude: (1) Assess needs through ongoing community outreach and engagement efforts to prioritize initiatives and research in our catchment areas. We monitor the cancer burden, needs, opportunities, and challenges in each catchment area; assess the impact of the MCCC's and institutional investment in outreach and cancer disparities infrastructure; and extend meaningful partnerships with our community-based affiliations and engage our Community Advisory Boards to help set priorities. (2) Implement and facilitate evidence-based programs and research to reduce cancer burden in our catchment areas (CAs). We identify COE-inspired opportunities for cancer research by MCCC investigators, especially where needs for data to support impactful change and implementation can be encouraged; enhance communications strategies to increase awareness of CAs among MCCC investigators (messaging, MCCC newsletters, seminars); promote use of COE research expertise and infrastructure resources (community outreach workers, study coordinators, partnership opportunities) to increase diversity of participants in research; and promote cancer research strategies that address barriers and disparities in the rural populations of our CAs. (3) Evaluate the impact of MCCC and monitor needs for research and expertise in the MCCC CAs and beyond. We contribute leadership and participation in our state cancer plans and facilitate academic and community collaborations to effect policy change; and foster MCCC relationships with Native American tribes across the US. Through COE, MCCC is committed to decreasing cancer incidence and mortality in its catchment areas. Our research in cancer risk assessment, prevention, screening, treatment, and survivorship enhances activities that address community needs. Through our research and engagement in our catchment areas we have an impact at all levels, from the individual to providers to policy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015083-47
Application #
10113621
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-04-25
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
47
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Dasari, Surendra; Newsom, Sean A; Ehrlicher, Sarah E et al. (2018) Remodeling of skeletal muscle mitochondrial proteome with high-fat diet involves greater changes to ?-oxidation than electron transfer proteins in mice. Am J Physiol Endocrinol Metab 315:E425-E434
Nowsheen, Somaira; Aziz, Khaled; Aziz, Asef et al. (2018) L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage. Nat Cell Biol 20:455-464
Razidlo, Gina L; Burton, Kevin M; McNiven, Mark A (2018) Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42. J Biol Chem 293:11143-11153
Wu, Dongyan; Yang, Haitao; Winham, Stacey J et al. (2018) Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer. J Hum Genet 63:339-348
Leon-Ferre, Roberto A; Polley, Mei-Yin; Liu, Heshan et al. (2018) Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat 167:89-99
Jahanseir, Khadijeh; Xing, Deyin; Greipp, Patricia T et al. (2018) PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants. Int J Gynecol Pathol 37:537-546
Painter, Jodie N; O'Mara, Tracy A; Morris, Andrew P et al. (2018) Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Med 7:1978-1987
Yu, Jia; Qin, Bo; Moyer, Ann M et al. (2018) DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest 128:2376-2388
Sugihara, Takaaki; Werneburg, Nathan W; Hernandez, Matthew C et al. (2018) YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity. Mol Cancer Res 16:1556-1567

Showing the most recent 10 out of 1129 publications